Ameritas Investment Partners, Inc. - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 62 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,531
-31.3%
8190.0%0.00%
Q2 2023$3,686
-26.3%
819
+6.5%
0.00%
Q1 2022$5,000
-50.0%
7690.0%0.00%
Q4 2021$10,000
-58.3%
7690.0%0.00%
-100.0%
Q3 2021$24,000
+9.1%
7690.0%0.00%0.0%
Q2 2021$22,000
-33.3%
7690.0%0.00%0.0%
Q1 2021$33,000
-40.0%
7690.0%0.00%
-66.7%
Q4 2020$55,0007690.00%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Orbimed Advisors 10,039,691$313,740,0003.45%
Baker Brothers Advisors 10,123,824$316,370,0001.39%
Logos Global Management LP 400,000$12,500,0000.90%
HHLR ADVISORS, LTD. 583,333$18,229,0000.24%
Rock Springs Capital Management LP 362,359$11,324,0000.24%
Virtus ETF Advisers LLC 6,292$197,0000.09%
FEDERATED HERMES, INC. 408,100$12,753,0000.02%
Virtu Financial LLC 7,940$248,0000.02%
UBS ASSET MANAGEMENT AMERICAS LLC 1,483,319$46,353,719,0000.02%
FMR LLC 7,055,666$220,489,0000.02%
View complete list of PRELUDE THERAPEUTICS INC shareholders